up to now several years, the UK has witnessed a revolution in clinical excess weight‑decline treatments — through the introduction of semaglutide (Wegovy®) for the growing popularity of tirzepatide (Mounjaro®). Now, One more name is drawing awareness in both of those medical and community overall